Latest filing published 07 Jul 2026 for Damora Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Garrett Winslow on record concern Damora Therapeutics, Inc., in the capacity of board member. Over a trading history stretching from 23 June 2021 to 6 July 2026, the count stands at 7 filings.
Both buying and selling appear: 2 purchases worth €12k, against 1 sale worth €6,422. On balance, insiders were net buyers of €6,010. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 7 July 2026 came the latest disclosure, an open-market sale for €6,422 in Damora Therapeutics, Inc. The last insider purchase was made public on 6 December 2021, 1,777 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations